Biocon Stelara Settlement Places Firm Among Earlier US Rivals

Indian Biosimilars Giant Secures Early 2025 Launch Date For Ustekinumab

 
• By David Wallace
  
Jumping Queue Of Arrows
Biocon has jumped ahead of several other biosimilars • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business